PICO Advisory Sub-Committee – Applications considered
- 1700 – Totally thoracoscopic exclusion of the left atrial appendage for patients with non-valvular atrial fibrillation
- 1701 – Deep brain stimulation of the thalamus for the treatment of severe refractory epilepsy
- 1702 – Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours
- 1703 – Detection of minimal residual disease in patients with acute lymphoblastic leukaemia
- 1705 – Structured prenatal risk assessment for preterm preeclampsia
- 1706 – Angiogenic and anti-angiogenic markers for identification and management of preeclampsia
- 1707 – Measuring minimal residual disease in acute lymphoblastic leukaemia using next generation sequencing assays to guide treatment decision
- 1708 – RNA PCR testing to determine eligibility and treatment for PBS-subsidised bulevirtide for treatment of hepatitis delta virus
- 1711 – Review of MBS items for subacromial decompression